Prospective, Non-interventional Study Assessing Perioral Rejuvenation Procedure
Ориентир для пациента и семьи
Простыми словами
Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.
- Что изучают
- В протоколе указаны: Saypha® Rich, Saypha® Filler Lidocaine.
- Кому может быть актуально
- Состояния в реестре: Perioral Wrinkles, Crow's Feet, Lip Volume Enhancement, Lip Aging. Базовые параметры: от 18 лет · Все.
- Что важно проверить
- Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
- Где проводится
- Австрия
- Следующий шаг
- Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Не всё понятно в терминах? Прочитайте наш гид для пациентов →
Официальное название
A Prospective, Non-interventional, Single-Centre Study Assessing the Time Course of a Holistic Perioral Rejuvenation Procedure
Обзор
The goal of this observational study is to learn how a perioral rejuvenation procedure affects perioral line severity and lip volume over time in adults undergoing routine aesthetic treatment in a single clinical center. The main questions it aims to answer are: * What proportion of participants achieves a ≥1-point improvement from baseline on both the Lip Fullness Scale (LFS) and the Static Perioral Lines Assessment Scale (SPLAS) at Week 12? * How do skin wrinkling/surface roughness, lip and perioral volume, and patient satisfaction change over 6 and 12 weeks? Participants will: * Receive a routine (non-study-mandated) holistic perioral rejuvenation procedure as decided by their treating clinician. * Attend study visits at approximately baseline, Week 6, and Week 12. * Undergo independent clinical assessments (assessor not involved in treatment delivery) of LFS and SPLAS. * Have skin wrinkling and surface roughness documented by VISIA skin analysis (baseline, Week 6, Week 12). * Have lip and perioral volume measured by VECTRA M3 volume analysis (baseline, Week 6, Week 12). * Complete a standardized patient satisfaction questionnaire (Week 12).
Вмешательства
- Устройство Saypha® Rich
Device is used as part of routine clinical care. This observational study does not assign or modify treatment; it observes outcomes associated with device use. - Устройство Saypha® Filler Lidocaine
Device is used as part of routine clinical care. This observational study does not assign or modify treatment; it observes outcomes associated with device use.
Первичные конечные точки
- Proportion of participants with a combined ≥ 1-point improvement in perioral line severity and lip fullness at Week 12 [Срок оценки: Week 12]
Вторичные конечные точки (5)
- Change in skin wrinkling and surface roughness of the lips and perioral region assessed by VISIA® skin analysis [Срок оценки: Week 6, Week 12]
- Change in combined upper and lower lip fullness assessed by the Lip Fullness Scale (LFS) [Срок оценки: Week 6, Week 12]
- Change in perioral line severity assessed by the Static Perioral Lines Assessment Scale (SPLAS) [Срок оценки: Week 6, Week 12]
- Change in lip and perioral volume assessed by three-dimensional (3D) facial imaging [Срок оценки: Week 6, Week 12]
- Patient satisfaction with treatment assessed using a clinic-internal patient satisfaction questionnaire [Срок оценки: Week 12]
Критерии участия
Критерии включения
- 18 years or older at time of treatment.
- At least mild static perioral lines and maximum of thin lips, as assessed by the investigator.
- Participant has a stable medical condition with no uncontrolled systemic disease.
- Willingness to participate in the routine follow-up after 12 weeks and a signed ICF.
- Participant already visiting the clinic for the specific treatment.
Критерии исключения
- Pregnancy and breast feeding.
- Known impairment of blood coagulation.
- Presence of acute infection or inflammation at the proposed injection sites.
- Hyaluronic Acid-Filler treatment in the perioral area within the last 6 months.
- Patients with a history of autoimmune disease or who are receiving immune therapy.
- History of hypersensitivity to hyaluronic acid, lidocaine hydrochloride or other amidetype local anaesthetics.
Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.
Здоровые добровольцы: Да
Дизайн исследования
- Модель наблюдения
- Когортное
Центры проведения
Австрия · 1 центр
- YUVELL — Vienna
Идентификаторы
NCT: NCT07398768 · YUV-NIS-003